Search research articles
Contact Us
Filters
Showing results (381-390 of 399) with videos related to
Page
of 40
Sort By:
Clinical Spine Surgery
|
March 16, 2024
Radiology Reports Do Not Accurately Portray the Severity of Cervical Neural Foraminal Stenosis
Yunsoo Lee, Tariq Ziad Issa, Aditya S Mazmudar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2024
Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients
C Robert, G V Long, J Larkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
T K Choueiri, R J Motzer, B I Rini, et al.
Oncogene
|
March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial
T K Choueiri, K Penkov, H Uemura, et al.
The Lancet. Oncology
|
October 23, 2018
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon H Loge, Matti Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Acta Neuropathologica Communications
|
June 2, 2016
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
Donato Iacovazzo, Richard Caswell, Benjamin Bunce, et al.
BMC Palliative Care
|
December 29, 2021
Effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with advanced cancer and their family caregivers (DIAdIC): study protocol for an international randomized controlled trial
Orphé Matthys, Aline De Vleminck, Sigrid Dierickx, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 399) with videos related to
Sort By:
Page
of 40
Clinical Spine Surgery
|
March 16, 2024
Radiology Reports Do Not Accurately Portray the Severity of Cervical Neural Foraminal Stenosis
Yunsoo Lee, Tariq Ziad Issa, Aditya S Mazmudar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2024
Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients
C Robert, G V Long, J Larkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
T K Choueiri, R J Motzer, B I Rini, et al.
Oncogene
|
March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial
T K Choueiri, K Penkov, H Uemura, et al.
The Lancet. Oncology
|
October 23, 2018
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon H Loge, Matti Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Acta Neuropathologica Communications
|
June 2, 2016
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
Donato Iacovazzo, Richard Caswell, Benjamin Bunce, et al.
BMC Palliative Care
|
December 29, 2021
Effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with advanced cancer and their family caregivers (DIAdIC): study protocol for an international randomized controlled trial
Orphé Matthys, Aline De Vleminck, Sigrid Dierickx, et al.
Page
of 40